Intravenous DNase I for the Treatment of Sepsis (IDEALSepsisI)

Abroad (travel likely)RecruitingPHASE1

Conditions

Sepsis · Critical Illness

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Hamilton Health Sciences, Hamilton, Ontario, Canada
Contact: Study coordinator (Alison E Fox-Robichaud, MD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Pathological Myeloid Activation After Sepsis and Trauma

Trauma Injury · Sepsis · Immunosuppression

Abroad (travel likely)Recruiting

Gainesville, United States

The Gut Microbiome - Source of Sepsis and Novel Target in Intensive Care Units?

Critical Illness · Intensive Care Unit Delirium · Neurocognitive Deficit

Abroad (travel likely)Recruiting

Jena, Germany

Prospective, Randomized Trial of Personalized Medicine With Pentaglobin® After Surgical Infectious Source Control in Patients With Peritonitis

Peritonitis · Sepsis · Septic Shock

Abroad (travel likely)RecruitingPHASE2

Vienna, Austria · Tübingen, Germany

Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?

Sepsis · Systemic Inflammatory Response Syndrome · Infection Mixed

Abroad (travel likely)Recruiting

Lansing, United States · Lansing, United States